Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Hwa Young Choi 5 Articles
Association between levels of physical activity and low handgrip strength: Korea National Health and Nutrition Examination Survey 2014-2019
Hyungsoon Ahn, Hwa Young Choi, Moran Ki
Epidemiol Health. 2022;44:e2022027.   Published online February 21, 2022
DOI: https://doi.org/10.4178/epih.e2022027
  • 5,328 View
  • 513 Download
  • 1 Citations
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
This study aimed to investigate the association between levels of physical activity (PA) and low handgrip strength in Korean adults.
METHODS
Our cross-sectional study design included 24,109 Korean adults older than 19 years of age who participated in the Korea National Health and Nutrition Examination Survey 2014–2019. Low handgrip strength is described as hand strength less than the cut-off value of the 20th percentile of handgrip strength from a healthy population in each gender and age group. PA was categorized into three levels (inactive, active, and highly active) according to the World Health Organization’s global recommendations on PA for health. Multivariable logistic regression analysis was used to examine the association between levels of PA and low handgrip strength.
RESULTS
Odds ratios (ORs) for low handgrip strength were significantly higher in middle-aged women who were active (adjusted odds ratio [aOR], 1.40; 95% confidence interval [CI], 1.15 to 1.69) and inactive (aOR, 1.47; 95% CI, 1.23 to 1.76) than in those highly active in walking exercise. Most of older people had significantly higher ORs for low handgrip strength in active compared to highly active in the context of aerobic, muscle strengthening, and walking exercise.
CONCLUSIONS
Walking exercise was associated with a lower risk of sarcopenia in middle-aged women and older individuals. However, further studies are necessary to confirm the causal relationship between levels of PA and low handgrip strength.
Summary
Korean summary
본 연구는 국민건강영양조사 2014-2019년도 자료를 활용하여 한국인 만 19세 이상 건강한 성인을 대상으로 낮은 악력의 기준값을 성별 및 연령그룹별로 도출하고 유산소 운동, 근력 운동, 걷기 운동 수준과 낮은 악력의 연관성을 분석하였다. 분석 결과, 중년 여성과 노년층에서 걷기 운동이 근감소증 발생의 예방과 연관성이 있음을 알 수 있었다.
Key Message
The association between levels of physical activity and low handgrip strength was different by sex and age groups. For women, walking exercise was associated with low handgrip strength, but not for men. By age groups, muscle strengthening exercise could help prevent sarcopenia in the young population, aerobic exercise has the potential to prevent sarcopenia in middle-aged individuals, and walking exercise could reduce sarcopenia risk in older individuals.

Citations

Citations to this article as recorded by  
  • Lower grip strength and insufficient physical activity can increase depressive symptoms among middle-aged and older European adults: a longitudinal study
    Han Zheng, Qingwen He, Hongyan Xu, Xiaowei Zheng, Yanfang Gu
    BMC Geriatrics.2022;[Epub]     CrossRef
Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea
Jin-Kyoung Oh, Hwa Young Choi, Minji Han, Yuh-Seog Jung, Sang Joon Lee, Moran Ki
Epidemiol Health. 2021;43:e2021019.   Published online March 10, 2021
DOI: https://doi.org/10.4178/epih.e2021019
  • 8,321 View
  • 298 Download
  • 1 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11 and is potentially preventable through vaccination. This study estimated the incidence of juvenile-onset RRP before the implementation of the national HPV vaccination program in Korea.
METHODS
We conducted a cohort study using claims data provided by a mandatory insurance program to estimate the incidence of RRP and associated healthcare use. Patients with juvenile RRP were defined as those aged ≤12 years with ≥2 admissions or ≥2 outpatient visits during which they received the International Classification of Diseases, 10th revision code for benign neoplasms of the larynx (D14.1).
RESULTS
During 2002-2014, 123 children (74 boys and 49 girls) were diagnosed with RRP. The patients had a mean of 6.5 person-years of follow-up. The incidence was estimated at 0.30/100,000 person-years. The median age at diagnosis was 4.0 years (mean, 4.3). Thirty-six (29.3%) patients underwent surgery, including 23 patients (18.7%) who underwent 2 or more surgical procedures. Severe disease, measured by more frequent surgical procedures and shorter time intervals between consecutive operations, was associated with a younger age at diagnosis.
CONCLUSIONS
The estimated incidence of juvenile-onset RRP in Korea was similar to that reported in other countries. The RRP burden should continue to be monitored using National Health Insurance Service claims data.
Summary
Korean summary
재발성호흡기유두종증은 사람유두종바이러스에 의해 발현되는 희귀 질환이다. 건강보험 청구자료를 활용하여 2002년 이후 출생아 전수 중 2014년까지 후두양성종양으로 2회이상 입원 또는 2회이상 외래진료를 받은 어린이 코호트를 관찰하여 재발성호흡기유두종증 발생률을 추정하였다. 총 123명의 재발성호흡기유두종증 환자가 발생하였으며 (발생률 10만인년당 0.30명), 평균 첫 진단시기는 4세인 것으로 나타났다. 2회 이상 수술적 치료를 받은 경우는 18.7%였다.
Key Message
Recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus (HPV). We conducted a cohort study using claims data to estimate the incidence of RRP. Patients with juvenile RRP were defined as those aged ≤12 years with ≥2 admissions or ≥2 outpatient visits with diagnosis for benign neoplasms of the larynx. During 2002-2014, 123 children were diagnosed with RRP. The incidence was estimated at 0.30/100,000 person-years. The median age at diagnosis was 4.0 years. Twenty three patients (18.7%) underwent 2 or more surgical procedures.

Citations

Citations to this article as recorded by  
  • Global epidemiology of HPV-associated recurrent respiratory papillomatosis and effect of vaccination
    RY Seedat, FG Dikkers
    Future Virology.2022; 17(5): 265.     CrossRef
Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID
Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Moran Ki, Hwa Young Choi, Dahye Paik, Sook-Hyang Jeong
Epidemiol Health. 2021;43:e2021077.   Published online October 6, 2021
DOI: https://doi.org/10.4178/epih.e2021077
  • 4,799 View
  • 223 Download
  • 1 Citations
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
Injection drug use is a major risk factor for hepatitis C virus (HCV) infection; however, limited data on this topic are available in Korea. Thus, this study aimed to investigate the epidemiological and clinical characteristics, treatment uptake, and outcomes of HCV infection among people who inject drugs (PWID).
METHODS
We used the data from the Korea HCV cohort, which prospectively enrolled patients with HCV infection between 2007 and 2019. Clinical data and results of a questionnaire survey on lifetime risk factors for HCV infection were analyzed according to a self-reported history of injection drug use (PWID vs. non-PWID group).
RESULTS
Among the 2,468 patients, 166 (6.7%) were in the PWID group, which contained younger patients (50.6±8.2 vs. 58.2±13.1 years) and a higher proportion of male (81.9 vs. 48.8%) than the non-PWID group. The distribution of PWID showed significant regional variations. Exposure to other risk factors for HCV infection was different between the groups. The proportion of patients with genotype non-2 infection was higher in the PWID group. Treatment uptake was higher in the PWID group in the interferon era; however, it was comparable between the groups in the direct-acting antiviral era. The rate of sustained virological response did not significantly differ between the groups.
CONCLUSIONS
As of 2019, PWID constituted a minority of HCV-infected people in Korea. The epidemiological characteristics, but not treatment uptake and outcomes, were different between the PWID and non-PWID groups. Therefore, active HCV screening and treatment should be offered to PWID in Korea.
Summary
Korean summary
1. 국내 C형간염 환자 중 정맥주사 사용자의 비율은 6.7%로 서구에 비하면 낮은 편이며, 지역별로 차이가 있다. 2. C형간염 환자 중 정맥주사 사용자는 비사용자에 비하여 연령, 성별 및 C형간염 위험 요인 노출 등에서 상이한 역학적 특성을 보인다. 3. 정맥주사 사용자의 C형간염 치료 수용률이나 치료 성공률은 비사용자와 비슷하다.
Key Message
As of 2019, PWID comprised a minority (6.7%) of all HCV-infected people in South Korea. The epidemiological features of the PWID group were different from those of the non-PWID group in terms of age, sex and exposure to risk factors of HCV infection. However, the treatment uptake and outcomes were not significantly different between these 2 groups in DAA era. Therefore, considering the global and national increase in the number of PWID and the contribution of PWID to new cases of HCV infection, active screening and treatment should be offered to PWID in Korea.

Citations

Citations to this article as recorded by  
  • Prevalence and factors associated with hepatitis C among pregnant women in China: a cross-sectional study
    Sun He, Gao Shuang, Wu Yinglan, Wang Lan, Wang Wei, Wang Ailing, Wang Changhe, Wang Xiaoyan, Gao Qun, Lu Zechun, Huang Dongxu, Wang Yu, Mo Phoenix Kit Han, Chen Zhongdan, Polin Chan, Wang Qian
    Scientific Reports.2023;[Epub]     CrossRef
Current status of hepatitis C virus infection and countermeasures in South Korea
Sook-Hyang Jeong, Eun Sun Jang, Hwa Young Choi, Kyung-Ah Kim, Wankyo Chung, Moran Ki
Epidemiol Health. 2017;39:e2017017.   Published online April 13, 2017
DOI: https://doi.org/10.4178/epih.e2017017
  • 20,506 View
  • 339 Download
  • 23 Citations
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
Hepatitis C virus (HCV) infection is a major cause of liver cirrhosis, hepatocellular carcinoma, and liver-related mortality. The new antiviral drugs against HCV, direct acting antivirals, result in >90% cure rate. This review aimed to summarize the current prevalence, clinical characteristics, outcomes, and treatment response associated with HCV infection, and countermeasures for optimal HCV control in South Korea. Based on a literature review, the current anti-HCV prevalence in the Korean population is 0.6 to 0.8%, with increasing prevalence according to age. The major HCV genotypes in Korean patients were genotype 1b and genotype 2. Successful antiviral treatment leads to significantly reduced liver related complications and mortality. However, only about one third of the individuals with HCV infection seem to be managed under the current national health insurance system, suggesting a remarkable rate of underdiagnoses and subsequent loss of opportunity to cure. A recent study in South Korea showed that targeted population screening for HCV infection is cost-effective. To prevent recently developed clusters of HCV infection in some clinics, mandatory surveillance rather than sentinel surveillance for HCV infection is required and governmental countermeasures to prevent reuse of syringes or other medical devises, and public education should be maintained. Moreover, one-time screening for a targeted population should be considered and a cost-effectiveness study supporting an optimal screening strategy is warranted.
Summary
Korean summary
우리나라 C형간염 유병률은 1% 미만(0.6-0.8%)이며, 수혈에 의한 C형간염은 더 이상 발생하지 않을 것으로 보인다. 그러나 최근 의료기관에서 C형간염 집단감염이 발생하여 국가적 대응이 필요한 공중보건의 문제로 떠올랐다. 2016년 부터는 C형간염을 완치할 수 있는 효과적이고 안전한 약제가 건강보험급여로 인정되어 이미 진단된 환자들에서는 효과적인 치료가 시작되었다. 그러나 진단되지 않은 상태에서 간질환이 진행되고 있는 환자들을 발굴하기 위해 국가 검진체계와 연계하여 선별검사를 시행한다면, 단기적으로는 진단과 치료비용 부담이 커지겠지만 장기적으로 사망률을 감소시키고, 삶의 질을 높이는 비용효과적인 C형간염 퇴치 전략이 될 것이다.
Key Message

Citations

Citations to this article as recorded by  
  • Effect of Disease-related Knowledge and Health Enhancement Lifestyle on Self-management Behavior among Chronic Hepatitis C Patients
    Hoo Jeung CHO, Euna PARK
    THE JOURNAL OF FISHERIES AND MARINE SCIENCES EDUCATION.2022; 34(2): 219.     CrossRef
  • Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
    Mi Seon Park, Young-Mo Yang, Ki Hyun Park, Hyonok Yoon, Ju Sin Kim, Eun Joo Choi
    Korean Journal of Clinical Pharmacy.2022; 32(3): 191.     CrossRef
  • Analysis of Hepatitis C Virus Genotypes and RNA Quantitative Values in Cheonan, Republic of Korea from 2007 to 2016
    Bishguurmaa Renchindorj, Bo Kyeung Jung, Joowon Park
    Microbiology and Biotechnology Letters.2022; 50(3): 422.     CrossRef
  • Comparative evaluation of Elecsys, Atellica, and Alinity assays for measuring the anti-Hepatitis C virus (HCV) antibody
    Youn Keong Cho, Sinyoung Kim, Hyun Ok Kim, Da Som Choi, Hyon-Suk Kim, Younhee Park
    Journal of Clinical Virology.2021; 141: 104910.     CrossRef
  • Performance Evaluation of Aptima HBV and HCV Quant Assays in the Panther System
    Yu Jeong Choi, Boyeon Kim, Yoonjung Kim, Kyung-A Lee
    Laboratory Medicine Online.2021; 11(3): 177.     CrossRef
  • Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea
    Youngmee Jee
    Global Health & Medicine.2021; 3(5): 288.     CrossRef
  • Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea
    Dae Hyun Lim, Jae Yoon Jeong, Seongwoo Nam, Jongkyoung Choi, Hyeok Choon Kwon, Yong Bum Yoon, Yeonjae Kim, BumSik Chin
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials
    Jeong Heo, Yoon Jun Kim, Jin-Woo Lee, Ji Hoon Kim, Young-Suk Lim, Kwang-Hyub Han, Sook-Hyang Jeong, Mong Cho, Ki Tae Yoon, Si Hyun Bae, Eric D. Crown, Linda M. Fredrick, Negar Niki Alami, Armen Asatryan, Do Hyun Kim, Seung Woon Paik, Youn-Jae Lee
    Gut and Liver.2021; 15(6): 895.     CrossRef
  • A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea
    Yong Kyun Won, Kyung Sik Kang, Yuri Sanchez Gonzalez, Homie Razavi, Ellen Dugan, Kwang-Hyub Han, Sang Hoon Ahn, Mi Young Jeon, Do Young Kim, Tatsuo Kanda
    PLOS ONE.2020; 15(4): e0232186.     CrossRef
  • Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
    Won Young Jang, Woo Jin Chung, Byoung Kuk Jang, Jae Seok Hwang, Heon Ju Lee, Moon Joo Hwang, Young Oh Kweon, Won Young Tak, Soo Young Park, Su Hyun Lee, Chang Hyeong Lee, Byung Seok Kim, Si Hye Kim, Jeong Ill Suh, Jun Gi Park
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population
    Kyung-Ah Kim, Wankyo Chung, Hwa Young Choi, Moran Ki, Eun Sun Jang, Sook-Hyang Jeong
    Liver International.2019; 39(1): 60.     CrossRef
  • Cost‐effectiveness of sofosbuvir plus ribavirin therapy for hepatitis C virus genotype 2 infection in South Korea
    Wankyo Chung, Kyung‐Ah Kim, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook‐Hyang Jeong
    Journal of Gastroenterology and Hepatology.2019; 34(4): 776.     CrossRef
  • The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort
    Chanyang Min, Woo Jin Bang, Miyoung Kim, Dong Jun Oh, Hyo Geun Choi
    Archives of Osteoporosis.2019;[Epub]     CrossRef
  • Apolipoprotein E Genotype and Expression Correlated with Hepatitis C Virus Genotype and Infection
    Gyu-Nam Park, Hyun-Jung Jo, Hye-Ran Kim, Min-Ju Kim, Kyung-A Shin, Seung-Bok Hong, Kyung-Soo Chang
    Journal of Bacteriology and Virology.2019; 49(1): 27.     CrossRef
  • Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
    Byung-Woo Kim, Chang-Mo Oh, Hwa Young Choi, Joong-Won Park, Hyunsoon Cho, Moran Ki
    Gut and Liver.2019; 13(1): 104.     CrossRef
  • The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
    Eun Sun Jang, Moran Ki, Hwa Young Choi, Kyung-Ah Kim, Sook-Hyang Jeong
    Hepatology International.2019; 13(5): 599.     CrossRef
  • Analysis on Usefulness of Non-invasive Liver Fibrosis Evaluation Method according to the Liver Disease : Focused on H ep atitis C p atients
    Nam Ji-Hee, Kim Jung-Hoon
    Journal of Radiological Science and Technology.2019; 42(5): 345.     CrossRef
  • Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
    Jungyeon Kim, Markus Haacker, Salmaan Keshavjee, Rifat Atun
    BMJ Global Health.2019; 4(3): e001441.     CrossRef
  • Updates on Cancer Epidemiology in Korea, 2018
    Sun-Seog Kweon
    Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
  • Factors influencing on health-related quality of life in South Korean with chronic liver disease
    Hyun Jin Kim, Hyeonsik Chu, Seonhye Lee
    Health and Quality of Life Outcomes.2018;[Epub]     CrossRef
  • Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
    Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
    Clinical and Molecular Hepatology.2018; 24(3): 311.     CrossRef
  • Changes in Quality of Life of Chronic Hepatitis C Patients Participating in Clinical Trial
    Hoo-Jeung CHO, Euna PARK
    JOURNAL OF FISHRIES AND MARINE SCIENCES EDUCATION.2018; 30(5): 1725.     CrossRef
  • Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
    Do Young Kim
    Gut and Liver.2017; 11(6): 745.     CrossRef
Prevalence of fungal infections using National Health Insurance data from 2009-2013, South Korea
Hee Jung Yoon, Hwa Young Choi, Young Kwon Kim, Yeong Jun Song, Moran Ki
Epidemiol Health. 2014;36:e2014017.   Published online September 11, 2014
DOI: https://doi.org/10.4178/epih/e2014017
  • 18,756 View
  • 249 Download
  • 22 Citations
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The symptoms of fungal infections vary from minor to severe. According to recent reports, fungal infection prevalence is increasing due to increases in the aging population and in patients with compromised immune systems. However, the total prevalence of fungal infections in South Korea is unknown. We investigated the recent 5-year prevalence of each type of fungal infection in South Korea across age, sex, and regional groups.
METHODS
Nationwide data from the National Health Insurance of South Korea were used. The target population included patients who had received treatment for a fungal infection that was listed as the main disease. For each patient, multiple treatments were counted as one case per year in the data analysis.
RESULTS
The annual prevalence of all-type mycoses increased from 6.9% in 2009 to 7.4% in 2013. Among the specific groups, the prevalence of dermatophytosis was highest (5.2%), followed by that of opportunistic mycoses (1.7%) and superficial mycoses (0.2%). The prevalence of subcutaneous mycoses and generalized mycoses was very low (8 cases per 100,000 persons and 3 cases per 1 million persons, respectively).
CONCLUSIONS
Every year, approximately 7.1% of the Korean population receives treatment for fungal diseases. Cases of opportunistic mycoses are assumed to increase each year. Therefore, further research is needed to understand and monitor the prevalence of mycoses to establish management policies to reduce the burden of fungal diseases.
Summary
Korean summary
2009-2013년도 한국의 건강보험자료를 활용하여 진균 종류별로 연령별, 성별, 지역별 유병률을 검토하였다. 그 결과 한국 인구의 약 7.1%가 매년 진균 질환으로 치료를 받고 있는 것으로 나타났다. 특히 기회감염 진균증의 연도별 증가 양상이 관찰되었다. 진균증 유병률에 대한 이해와 관심이 필요하며 이를 토대로 진균 질환 관리 정책 수립이 필요하다.
Key Message

Citations

Citations to this article as recorded by  
  • Treatment and economic burden of mucormycosis in China: Case report review and burden estimation
    Yifei Jian, Minggui Wang, Yue Yu, Yongjia Zhuo, Dunming Xiao, Sisi Lin, Jianwei Xuan
    Journal of Clinical Pharmacy and Therapeutics.2022; 47(7): 905.     CrossRef
  • Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study
    Javad Javidnia, Zahra Ghotbi, Aynaz Ghojoghi, Kavous Solhjoo, Mohamed Mahdi Alshahni, Seyed Ali Jeddi, Bahram Ahmadi, Sadegh Nouripour-Sisakht, Saham Ansari, Gholamreza Shokoohi
    Mycopathologia.2022; 187(2-3): 225.     CrossRef
  • Carbon nanostructures: a comprehensive review of potential applications and toxic effects
    Maryam Farmand, Fatemeh Jahanpeyma, Alieh Gholaminejad, Mostafa Azimzadeh, Fatemeh Malaei, Nahid Shoaie
    3 Biotech.2022;[Epub]     CrossRef
  • Risk factors of dermatophytosis among Korean adults
    Joon Ho Son, Jee Yun Doh, Kyungdo Han, Yeong Ho Kim, Ju Hee Han, Chul Hwan Bang, Young Min Park, Ji Hyun Lee
    Scientific Reports.2022;[Epub]     CrossRef
  • Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in eastern Guangdong region: A retrospective study of the past 10 years
    Hazrat Bilal, Bing Hou, Muhammad Shafiq, Xinyu Chen, Muhammad Akbar Shahid, Yuebin Zeng
    Frontiers in Microbiology.2022;[Epub]     CrossRef
  • Real-world Adverse Events Associated with Fluconazole and Itraconazole: Analysis of Nationwide Data Using a Spontaneous Reporting System Database
    Yu gyeong Lee, Jungmin Lee, Pusoon Chun
    Korean Journal of Clinical Pharmacy.2022; 32(3): 204.     CrossRef
  • Diagnosis and Treatment of Invasive Mold Diseases
    Sang-Oh Lee
    Infection & Chemotherapy.2022;[Epub]     CrossRef
  • Detection of antifungal drug-resistant and ERG11 gene mutations among clinical isolates of Candida species isolated from Khartoum, Sudan.
    Ahmed Osman Mohamed, Malik Suliman Mohamed, Mohamed Abdelrahman Hussain, Ibrahim Fatahalrahman Ahmed
    F1000Research.2021; 9: 1050.     CrossRef
  • Antifungal Properties of Essential Oils and Their Compounds for Application in Skin Fungal Infections: Conventional and Nonconventional Approaches
    Aswir Abd Rashed, Devi-Nair Gunasegavan Rathi, Nor Atikah Husna Ahmad Nasir, Ahmad Zuhairi Abd Rahman
    Molecules.2021; 26(4): 1093.     CrossRef
  • The impact of obesity on immune response to infection: Plausible mechanisms and outcomes
    Giovanna Muscogiuri, Gabriella Pugliese, Daniela Laudisio, Bianca Castellucci, Luigi Barrea, Silvia Savastano, Annamaria Colao
    Obesity Reviews.2021;[Epub]     CrossRef
  • Copper as an antimicrobial agent: recent advances
    Intisar Salah, Ivan P. Parkin, Elaine Allan
    RSC Advances.2021; 11(30): 18179.     CrossRef
  • Prevalence of superficial‐cutaneous fungal infections in Shiraz, Iran: A five‐year retrospective study (2015–2019)
    Hossein Khodadadi, Kamiar Zomorodian, Hasti Nouraei, Zahra Zareshahrabadi, Sajjad Barzegar, Mohammad Reza Zare, Keyvan Pakshir
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • Janus-Faced Molecules against Plant Pathogenic Fungi
    Gaspar Banfalvi
    International Journal of Molecular Sciences.2021; 22(22): 12323.     CrossRef
  • Detection of antifungal drug-resistant and ERG11 gene mutations among clinical isolates of Candida species isolated from Khartoum, Sudan.
    Ahmed Osman Mohamed, Malik Suliman Mohamed, Mohamed Abdelrahman Hussain, Ibrahim Fatahalrahman Ahmed
    F1000Research.2020; 9: 1050.     CrossRef
  • Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea
    Hyunseok Cho, Jae-Woo Kwon
    The Korean Journal of Internal Medicine.2019; 34(3): 643.     CrossRef
  • Mycoses in northeastern Brazil: epidemiology and prevalence of fungal species in 8 years of retrospective analysis in Alagoas
    Fernanda Cristina de Albuquerque Maranhão, Jorge Belém Oliveira-Júnior, Maria Anilda dos Santos Araújo, Denise Maria Wanderlei Silva
    Brazilian Journal of Microbiology.2019; 50(4): 969.     CrossRef
  • Identification and Functional Testing of Novel Interacting Protein Partners for the Stress Sensors Wsc1p and Mid2p ofSaccharomyces cerevisiae
    Ednalise Santiago-Cartagena, Sahily González-Crespo, Vladimir Vélez, Nelson Martínez, Jamie Snider, Matthew Jessulat, Hiroyuki Aoki, Zoran Minic, Pearl Akamine, Inoushka Mejías, Luis M Pérez, Brian C Rymond, Mohan Babu, Igor Stagljar, José R Rodríguez-Med
    G3 Genes|Genomes|Genetics.2019; 9(4): 1085.     CrossRef
  • Structure of Aspergillus fumigatus Cytosolic Thiolase: Trapped Tetrahedral Reaction Intermediates and Activation by Monovalent Cations
    Andrew C. Marshall, Charles S. Bond, John B. Bruning
    ACS Catalysis.2018; 8(3): 1973.     CrossRef
  • Clinical and Laboratory Characteristics and Mortality in Korean Patients with Systemic Sclerosis: A Nationwide Multicenter Retrospective Cohort Study
    Ki Won Moon, Shin-Seok Lee, Yun Jong Lee, Jae-Bum Jun, Su-Jin Yoo, Ji Hyeon Ju, Sung Hae Chang, In Ah Choi, Tae Young Kang, Eun Bong Lee, Seung-Geun Lee
    The Journal of Rheumatology.2018; 45(9): 1281.     CrossRef
  • Genetic Variations ofTrichophyton rubrumClinical Isolates from Korea
    Nam-Sup Yoon, Hyunjung Kim, Sung-Bae Park, Min Park, Sunghyun Kim, Young-Kwon Kim
    Biomedical Science Letters.2018; 24(3): 221.     CrossRef
  • Structure of the sliding clamp from the fungal pathogen Aspergillus fumigatus (Afum PCNA ) and interactions with Human p21
    Andrew C. Marshall, Alice J. Kroker, Lauren A.M. Murray, Kahlia Gronthos, Harinda Rajapaksha, Kate L. Wegener, John B. Bruning
    The FEBS Journal.2017; 284(6): 985.     CrossRef
  • Burden of fungal infections in Qatar
    Saad J. Taj-Aldeen, Prem Chandra, David W. Denning
    Mycoses.2015; 58: 51.     CrossRef

Epidemiol Health : Epidemiology and Health